Rysman E,Brusselmans K,Scheys K,et al.De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation[J].Cancer Res,2010,70(20):8 117-8 126.
[2]
Migita T,Narita T,Nomura K,et al.ATP citrate lyase:activation and therapeutic implications in nonsmall cell lung cancer[J].Cancer Res,2008,68(20):8 547-8 554.
[3]
Zaidi N,Swinnen JV,Smans K.ATP-citrate lyase:a key player in cancer metabolism[J].Cancer Res,2012,72(15):3 709-3 714.
Furuta E,Okuda H,Kobayashi A,et al.Metabolic genes in cancer:their roles in tumor progression and clinical implications[J].Biochim Biophys Acta,2010,1 805(2):141-152.
[6]
Menendez JA,Lupu R.Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis[J].Nat Rev Cancer,2007,7(10):763-777.
[7]
Hanai JI,Doro N,Sasaki AT,et al.Inhibition of lung cancer growth:ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-actiated protein kinase(MAPK)and phosphatidylinositol-3-kinase(PI3K)/AKT pathways[J].J Cell Physiol,2012,227(4):1 709-1 720.
